Abstract:OBJECTIVE:This study was designed to compare the short-term and long-term effects of oral rehydration salts, oral rehydration salts plus metoprolol or oral rehydration salts plus midodrine hydrochloride on the treatment of postural tachycardia syndrome (POTS) in children.METHOD:A total of 118 children with POTS were divided into oral rehydration salts group (n = 39), metoprolol group (oral rehydration salts plus metoprolol, n = 10) or midodrine hydrochloride group (oral rehydration salts plus midodrine hydrochloride, n = 69). The patients were followed up in clinics or over telephone for 3 - 18 months, with a mean of (11.7 ± 4.1) months. The symptom scores were recorded before treatment, after 3 months and at the end of the follow-up. Reduction of the score by 2 points or more was considered that the treatment was effective. The effective rate in 3 months was applied to evaluate short-term effects of 3 different therapies by chi-square test. Taking futility as events, Kaplan-Meier curves were drawn to compare long-term effects of the 3 different therapies in treating POTS in children.RESULT:No significant differences among the 3 groups were found in sex, age, body height, weight, the symptom scores before treatment or hemodynamic variables. Oral rehydration salts, metoprolol and midodrine hydrochloride improved clinical symptoms after 3 months. The symptom scores of the 3 groups before treatment and after 3 months were 2.4 ± 3.2 vs. 5.5 ± 2.9, 2.2 ± 3.0 vs. 6.1 ± 3.0 and 1.9 ± 1.6 vs. 5.9 ± 2.7, respectively. The difference was significant (P < 0.05). Descending order of the short-term effective rate was 91.3% in midodrine hydrochloride group, 80.0% in metoprolol group and 74.4% in oral rehydration salts group. The difference was significant (χ(2) = 5.85, P < 0.05). All the 3 different therapies improved clinical symptoms at the end of follow-up. The symptom scores were 2.6 ± 3.2 vs. 5.6 ± 2.9, 2.5 ± 3.1 vs. 6.1 ± 3.0 and 2.2 ± 2.1 vs. 6.0 ± 2.7, respectively. (P < 0.05). The result of the Kaplan-Meier curves showed that the long-term effect of midodrine hydrochloride was significantly superior to metoprolol group and oral rehydration salts group (P < 0.05). There was no significant difference between the latter two groups.CONCLUSION:Oral rehydration salts plus midodrine hydrochloride or plus metoprolol improved the efficacy of drugs in children with POTS. And the efficacy of midodrine hydrochloride was superior to that of metoprolol.

[Predictive Value of Baseline Plasma Midregional Fragment of Pro-Adrenomedullin Level on Long-Term Outcome of Postural Tachycardia Syndrome Children Treated with Midodrine Hydrochloride].

Midregional Pro-Adrenomedullin As a Predictor for Therapeutic Response to Midodrine Hydrochloride in Children with Postural Orthostatic Tachycardia Syndrome.

Predictive value of upright blood pressure change for long-term prognosis of children with postural tachycardia syndrome treated with midodrine hydrochloride

Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome.

Difference Between Supine and Upright Blood Pressure Associates to the Efficacy of Midodrine on Postural Orthostatic Tachycardia Syndrome (POTS) in Children

The Follow-Up Study on the Treatment of Children with Postural Orthostatic Tachycardia Syndrome

Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children.

Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.

The Prognostic Meaning of Biomarkers and Hemodynamic Parameters in the Postural Tachycardia Syndrome Children Treated with Midodrine Hydrochloride

A signal center follow-up study on the treatment of postural tachycardia syndrome in children

A time-effect analysis of postural orthostatic tachycardia syndrome treated with midodrine hydrochloride in children

[Effect of Selective Alpha1 Receptor Agonist in the Treatment of Children with Postural Orthostatic Tachycardia Syndrome].

Therapies for Postural Tachycardia Syndrome in Children

P29 Children suffering from postural orthostatic tachycardia syndrome with a marked increase in erythrocytic hydrogen sulfide have a better therapeutic response to midodrine hydrochloride

Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy

Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome

Postural Orthostatic Tachycardia Syndrome with Increased Erythrocytic Hydrogen Sulfide and Response to Midodrine Hydrochloride

Hemocytometric Measures Predict the Efficacy of Oral Rehydration for Children with Postural Tachycardia Syndrome.

Plasma C-type Natriuretic Peptide As a Predictor for Therapeutic Response to Metoprolol in Children with Postural Tachycardia Syndrome.

Heart Rate Variability Predicts Therapeutic Response to Metoprolol in Children with Postural Tachycardia Syndrome

Usefulness of Plasma Copeptin As a Biomarker to Predict the Therapeutic Effectiveness of Metoprolol for Postural Tachycardia Syndrome in Children